Search

everythinglearnresearchcommunity

for

Search:↓

Double-stranded RNA activates a pathway that causes a skin protein to be expressed in the wrong place.

BMP signaling controls hair growth and skin color.

Sulfotransferase SULT1A1 activity may predict minoxidil treatment success for hair loss.

Finasteride helps female-pattern hair loss.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Dermatologists often neglect hair disorders due to complexity and lack of clear treatments, impacting patient care and highlighting the need for better education and interest in this area.

There are significant gaps and inconsistencies in diagnosing and treating alopecia areata in Greece and Italy.

Low dose methotrexate does not increase hair fall and may reduce it.

Dupilumab may help hair regrowth in some patients with severe atopic dermatitis, but results vary.

Eating vitamin A affects hair growth and health by changing cell signals in mice.

Corticosteroids are the most common treatment for alopecia areata, but many patients need better options.

Using minoxidil and tofacitinib together can effectively treat severe hair loss.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

All four treatments for early rheumatoid arthritis had similar safety profiles.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Bee pollen, green tea, essential oils, and various plant extracts improve skin and hair health.

Certain immune cells in the skin release a protein that stops hair growth by keeping hair stem cells inactive.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Baricitinib 4 mg is effective and safe for treating severe alopecia areata.

Switching between the medications tofacitinib and baricitinib can be effective for treating hair loss in alopecia areata.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

OR-101 shows promise for treating alopecia areata by improving hair growth.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Both individual and combined treatments of tofacitinib and corticosteroids can help regrow hair in moderate-to-severe alopecia areata, but ongoing treatment may be necessary.

A new treatment using nanoparticles can effectively prevent and reduce hair loss caused by chemotherapy.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Patients with severe alopecia areata felt better and less anxious or depressed when treated with baricitinib compared to placebo.

Fractional lasers effectively treat alopecia areata, especially when combined with minoxidil or cortisol.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.